Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 28, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Alnylam Pharmaceuticals, Inc.
| 4.75K |
—
|
—
| +90.74% | 9.99K | +1 |
Mar 1
| ||||||
Alnylam Pharmaceuticals, Inc.
| 4.75K |
—
|
—
| +54.82% | 13.42K |
Mar 1
| |||||||
Alnylam Pharmaceuticals, Inc.
| 7.74K |
—
|
—
| +39.74% | 27.22K | +1 |
Mar 1
| ||||||
Alnylam Pharmaceuticals, Inc.
| 23.75K |
—
|
—
| +49.36% | 71.88K |
Mar 1
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$105.30 | -$2,762,570.94 |
—
|
0
|
Feb 29
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.17K |
$155.30 | -$77,805.43 | +28.65% | 5.24K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.33K |
$155.30 | -$89,144.57 | +7.35% | 19.48K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.99K |
$155.31 | -$455,357.07 | +6.62% | 48.13K |
Feb 27 - Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| 1.33K |
$155.30 | -$89,144.57 | +18.19% | 8.67K |
Feb 27 - Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| 549 |
$155.30 | -$51,094.50 | +15.32% | 4.13K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.99K |
$148.06 | -$193,665.96 | +68.75% | 7.33K |
Feb 15 - Feb 16
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.27K |
$148.06 | -$149,099.42 | +14.31% | 18.14K | +1 |
Feb 15 - Feb 16
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.27K |
$148.06 | -$149,396.69 | +125.99% | 4.07K | +1 |
Feb 15 - Feb 16
| ||||||
Alnylam Pharmaceuticals, Inc.
| 9.92K |
$148.06 | -$1,040,884.56 | +28.18% | 45.14K |
Feb 15 - Feb 16
| |||||||
Alnylam Pharmaceuticals, Inc.
| 3.58K |
$170.99 | -$272,050.04 |
∞
| 3.58K | +1 |
Feb 1 - Feb 2
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$145.73 | -$2,956,500.00 |
—
| 16.03K |
Dec 27
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$184.78 | -$1,409,305.89 |
—
| 4.34K |
Aug 3 - Aug 7
| |||||||
Alnylam Pharmaceuticals, Inc.
| 4.17K |
$185.85 | -$643,036.64 | +35.60% | 15.87K | +1 |
Aug 3 - Aug 4
| ||||||
Alnylam Pharmaceuticals, Inc.
| 4.88K |
$185.85 | -$753,986.38 | +16.10% | 35.22K |
Aug 3 - Aug 4
| |||||||
Alnylam Pharmaceuticals, Inc.
| 4.88K |
$185.85 | -$753,986.38 | +27.30% | 22.77K |
Aug 3 - Aug 4
| |||||||
Alnylam Pharmaceuticals, Inc.
| 16.03K |
$185.38 | -$1,195,310.07 |
∞
| 16.03K |
Aug 2 - Aug 3
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
| 9.34K |
$194.59 | -$1,481,811.47 | +44.47% | 30.33K |
Apr 26 - Apr 27
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.3K |
$194.59 | -$190,113.44 | +24.45% | 11.71K | +1 |
Apr 26 - Apr 27
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.8K |
$194.59 | -$287,214.96 |
∞
| 1.8K | +1 |
Apr 26 - Apr 27
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.92K |
$194.59 | -$465,464.02 | +19.51% | 17.89K |
Apr 26 - Apr 27
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$197.12 | -$846,449.96 |
—
| 4.34K |
Apr 26 - Apr 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| -3.50K |
$210.00 | -$735,000.00 | -100.00% |
0
| +1 |
Apr 6
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 7
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.